McKesson's Amoxicillin Deal: A Shot in the Arm?

McKesson stock jumps after securing a deal to distribute USAntibiotics' amoxicillin nationwide, potentially solving critical supply shortages. Is this a game-changer for the healthcare giant, or just a blip on their already impressive growth trajectory? Find out how this partnership could impact McKesson's stock and the future of U.S. pharmaceutical supply chains. Hosted on Acast. See acast.com/privacy for more information.